ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 118 filers reported holding ACCELERATE DIAGNOSTICS INC in Q4 2017. The put-call ratio across all filers is 1.52 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $162 | +15.7% | 200 | 0.0% | 0.00% | – |
| Q1 2023 | $140 | -0.7% | 200 | 0.0% | 0.00% | – |
| Q4 2022 | $141 | – | 200 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 200 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | – | 200 | +809.1% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 22 | -99.3% | 0.00% | – |
| Q3 2018 | $73,000 | +2.8% | 3,200 | 0.0% | 0.00% | – |
| Q2 2018 | $71,000 | -2.7% | 3,200 | 0.0% | 0.00% | – |
| Q1 2018 | $73,000 | -13.1% | 3,200 | 0.0% | 0.00% | – |
| Q4 2017 | $84,000 | +16.7% | 3,200 | 0.0% | 0.00% | – |
| Q3 2017 | $72,000 | -18.2% | 3,200 | 0.0% | 0.00% | – |
| Q2 2017 | $88,000 | +14.3% | 3,200 | 0.0% | 0.00% | – |
| Q1 2017 | $77,000 | +16.7% | 3,200 | 0.0% | 0.00% | – |
| Q4 2016 | $66,000 | +247.4% | 3,200 | +357.1% | 0.00% | – |
| Q3 2016 | $19,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 2,183,795 | $49,965,000 | 30.39% |
| ORACLE INVESTMENT MANAGEMENT INC | 4,356,363 | $99,674,000 | 21.44% |
| Selkirk Management LLC | 348,805 | $7,981,000 | 4.29% |
| Trellus Management Company, LLC | 55,502 | $1,270,000 | 1.72% |
| GRIFFIN ASSET MANAGEMENT, INC. | 550,046 | $12,585,000 | 1.60% |
| Belpointe Asset Management LLC | 272,459 | $6,234,000 | 1.23% |
| Cannell & Co. | 1,115,239 | $25,517,000 | 0.97% |
| CHARTIST INC /CA/ | 64,765 | $1,481,823,000 | 0.94% |
| Chicago Capital, LLC | 546,279 | $12,499,000 | 0.80% |
| OAKTOP CAPITAL MANAGEMENT II, L.P. | 155,000 | $3,546,000 | 0.76% |